SCHEMBL1435722

SCHEMBL1435722

NC(=S)NN=C/C=C/c1ccccc1F

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.68
POLB P06746 1/20 0.63
HTT P42858 1/20 0.63
NPSR1 Q6W5P4 1/20 0.63
EGFR P00533 1/20 0.56
GAA P10253 3/20 0.49
KDM4E B2RXH2 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
NFE2L2 Q16236 1/20 0.44
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
MPI P34949 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
KMT2A Q03164 1/20 0.43
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1435719 1.00 MAOB (0.68) MAOBPOLBHTTNPSR1EGFR
SCHEMBL1435721 1.00 MAOB (0.68) MAOBPOLBHTTNPSR1EGFR
SCHEMBL1435542 0.82 NPSR1 (0.63) MAOBPOLBHTTNPSR1EGFR
SCHEMBL1435512 0.82 NPSR1 (0.63) MAOBPOLBHTTNPSR1GAA
SCHEMBL1435539 0.82 NPSR1 (0.63) MAOBPOLBHTTNPSR1EGFR
SCHEMBL1435543 0.82 NPSR1 (0.63) MAOBPOLBHTTNPSR1EGFR
SCHEMBL1435509 0.82 NPSR1 (0.63) MAOBPOLBHTTNPSR1GAA
SCHEMBL1435511 0.82 NPSR1 (0.63) MAOBPOLBHTTNPSR1GAA
SCHEMBL7650941 0.81 MAOB (1.00) MAOBPOLBEGFRGAAKDM4E
SCHEMBL29522846 0.81 MAOB (1.00) MAOBPOLBEGFRGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1898908-B1 NOVEL CHEMICAL COMPOUNDS AND THE USES THEREOF AS A MEDICAMENT TROPHOS (FR) 2011-03-30 EP disclosed
US-20090203747-A1 NOVEL CHEMICAL COMPOUNDS AND THE USES THEREOF AS A MEDICINE TROPHOS PARC SCIENTIFIQUE LUMINY (FR) 2009-08-13 US disclosed
EP-1898908-A2 NOVEL CHEMICAL COMPOUNDS AND THE USES THEREOF AS A MEDICAMENT Trophos (FR) 2008-03-19 EP disclosed
WO-2007003767-A2 NOVEL CHEMICAL COMPOUNDS AND THE USES THEREOF AS A MEDICINE TROPHOS (FR) 2007-01-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203747-A1 NOVEL CHEMICAL COMPOUNDS AND THE USES THEREOF AS A MEDICINE NLN, NQO1, APP MAOB 47/4885POLB 4234/4885HTT 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.